1. Home
  2. VTRS vs NLY Comparison

VTRS vs NLY Comparison

Compare VTRS & NLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Viatris Inc.

VTRS

Viatris Inc.

HOLD

Current Price

$14.78

Market Cap

17.2B

Sector

Health Care

ML Signal

HOLD

Logo Annaly Capital Management Inc.

NLY

Annaly Capital Management Inc.

HOLD

Current Price

$22.75

Market Cap

15.2B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
VTRS
NLY
Founded
1961
1996
Country
United States
United States
Employees
30000
212
Industry
Medicinal Chemicals and Botanical Products
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
17.2B
15.2B
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
VTRS
NLY
Price
$14.78
$22.75
Analyst Decision
Buy
Buy
Analyst Count
4
11
Target Price
$13.50
$23.82
AVG Volume (30 Days)
8.0M
5.7M
Earning Date
05-07-2026
04-21-2026
Dividend Yield
3.24%
12.26%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$14,299,900,000.00
N/A
Revenue This Year
$4.41
$188.83
Revenue Next Year
$1.96
$2.40
P/E Ratio
N/A
$7.88
Revenue Growth
N/A
N/A
52 Week Low
$8.19
$18.43
52 Week High
$16.47
$24.52

Technical Indicators

Market Signals
Indicator
VTRS
NLY
Relative Strength Index (RSI) 60.97 57.89
Support Level $12.90 $22.20
Resistance Level $15.22 $23.27
Average True Range (ATR) 0.40 0.39
MACD 0.11 0.09
Stochastic Oscillator 75.68 78.35

Price Performance

Historical Comparison
VTRS
NLY

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

About NLY Annaly Capital Management Inc.

Annaly Capital Management Inc is an American mortgage real estate investment trust. Its business objective is to generate net income for distribution to its stockholders and optimize its returns through prudent management of its diversified investment strategies. The company's reportable operating segments are: the Agency segment, which invests in Agency mortgage-backed securities collateralized by residential mortgages; the Residential Credit segment, which invests in non-Agency residential whole loans and securitized products within the residential and commercial markets; the Mortgage Servicing Rights segment; and Corporate & Other. Maximum revenue for the company is generated from its Agency segment.

Share on Social Networks: